{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:56:02Z","timestamp":1757591762374,"version":"3.32.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,24]]},"DOI":"10.7759\/cureus.76313","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T15:13:14Z","timestamp":1735053194000},"source":"Crossref","is-referenced-by-count":1,"title":["Impact of Silymarin Supplementation on Liver Function and Enzyme Profiles in Diverse Chronic Liver Disease Etiologies"],"prefix":"10.7759","author":[{"given":"Muhammad Zohaib","family":"Amjad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Umair","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnoor","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arslan","family":"Shamim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz Muhammad","family":"Zeeshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohaib","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Irfan","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i41.5910","article-title":"Epidemiology of liver cirrhosis and associated complications: current knowledge and future directions","volume":"28","author":"Liu YB","year":"2022","unstructured":"Liu YB, Chen MK. Epidemiology of liver cirrhosis and associated complications: current knowledge and future directions. World J Gastroenterol. 2022, 28:5910-30. 10.3748\/wjg.v28.i41.5910","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-17948-6","article-title":"Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019","volume":"24","author":"Wu XN","year":"2024","unstructured":"Wu XN, Xue F, Zhang N, et al.. Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019. BMC Public Health. 2024, 24:363. 10.1186\/s12889-024-17948-6","journal-title":"BMC Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.22087\/hmj.v6i2.917","article-title":"Triple therapy with garlic, silymarin and curcumin in non-alcoholic fatty liver disease: a randomized, placebo-controlled clinical trial","volume":"6","author":"Ataee Z","year":"2021","unstructured":"Ataee Z, Vahabzadeh M, Shabnam S, Kiapey M, Rahimi HR. Triple therapy with garlic, silymarin and curcumin in non-alcoholic fatty liver disease: a randomized, placebo-controlled clinical trial. Herb Med J. 2021, 6:50-64. 10.22087\/hmj.v6i2.917","journal-title":"Herb Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56100544","article-title":"Silymarin in combination with vitamin C, vitamin E, coenzyme Q10 and selenomethionine to improve liver enzymes and blood lipid profile in NAFLD patients","volume":"56","author":"Curcio A","year":"2020","unstructured":"Curcio A, Romano A, Cuozzo S, et al.. Silymarin in combination with vitamin C, vitamin E, coenzyme Q10 and selenomethionine to improve liver enzymes and blood lipid profile in NAFLD patients. Medicina (Kaunas). 2020, 56:10.3390\/medicina56100544","journal-title":"Medicina (Kaunas)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221683","article-title":"Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: a randomized, double-blind, placebo controlled trial","volume":"14","author":"Navarro VJ","year":"2019","unstructured":"Navarro VJ, Belle SH, D'Amato M, et al.. Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: a randomized, double-blind, placebo controlled trial. PLoS One. 2019, 14:e0221683. 10.1371\/journal.pone.0221683","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01251-y","article-title":"Silymarin as supportive treatment in liver diseases: a narrative review","volume":"37","author":"Gillessen A","year":"2020","unstructured":"Gillessen A, Schmidt HH. Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther. 2020, 37:1279-301. 10.1007\/s12325-020-01251-y","journal-title":"Adv Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.101174","article-title":"Administration of silymarin in NAFLD\/NASH: a systematic review and meta-analysis","volume":"29","author":"Li S","year":"2024","unstructured":"Li S, Duan F, Li S, Lu B. Administration of silymarin in NAFLD\/NASH: a systematic review and meta-analysis. Ann Hepatol. 2024, 29:101174. 10.1016\/j.aohep.2023.101174","journal-title":"Ann Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18502\/abi.v1i2.14105","article-title":"The effect of silymarin on liver enzymes and serum lipid profiles in Iranian patients with non-alcoholic fatty liver disease: a double-blind randomized controlled trial","volume":"1","author":"Chahkandi S","year":"2023","unstructured":"Chahkandi S, Dabiri R, Mirmohammadkhani M, Amiri-Dashatan N, Koushki M. The effect of silymarin on liver enzymes and serum lipid profiles in Iranian patients with non-alcoholic fatty liver disease: a double-blind randomized controlled trial. Acta Biochim Iran. 2023, 1:83-9. 10.18502\/abi.v1i2.14105","journal-title":"Acta Biochim Iran"},{"key":"ref9","article-title":"A placebo-controlled trial of silymarin in patients with nonalcoholic fatty liver disease","volume":"9","author":"Hashemi SJ","year":"2009","unstructured":"Hashemi SJ, Hajiani E, Sardabi EH. A placebo-controlled trial of silymarin in patients with nonalcoholic fatty liver disease. Hepat Mon. 2009, 9:265-70.","journal-title":"Hepat Mon"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A randomized trial of silymarin for the treatment of\u00a0nonalcoholic steatohepatitis","volume":"15","author":"Wah Kheong C","year":"2017","unstructured":"Wah Kheong C, Nik Mustapha NR, Mahadeva S. A randomized trial of silymarin for the treatment of\u00a0nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2017, 15:1940-1949.e8. 10.1016\/j.cgh.2017.04.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2017.0051","article-title":"High dose of silymarin in patients with decompensated liver disease: a randomized controlled trial","volume":"37","author":"Fathalah WF","year":"2017","unstructured":"Fathalah WF, Abdel Aziz MA, Abou El Soud NH, El Raziky ME. High dose of silymarin in patients with decompensated liver disease: a randomized controlled trial. J Interferon Cytokine Res. 2017, 37:480-7. 10.1089\/jir.2017.0051","journal-title":"J Interferon Cytokine Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.53350\/pjmhs22168690","article-title":"The role of natural drug silymarinin in chronic liver disease patients","volume":"16","author":"Hussain S","year":"2022","unstructured":"Hussain S, Khan MO, Mustafa A, Shaheen G, Feroz S, Ahmad S. The role of natural drug silymarinin in chronic liver disease patients. Pakistan J Med Heal Sci. 2022, 16:690-4. 10.53350\/pjmhs22168690","journal-title":"Pakistan J Med Heal Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18502\/ijdo.v12i2.4046","article-title":"The efficacy of silymarin and vitamin E in non-alcoholic fatty liver disease: a clinical trial","volume":"12","author":"Akhondi-Meybodi M","year":"2020","unstructured":"Akhondi-Meybodi M, Baghbanian M, Namazi A. The efficacy of silymarin and vitamin E in non-alcoholic fatty liver disease: a clinical trial. Iran J diabetes Obes. 2020, 12:2-7. 10.18502\/ijdo.v12i2.4046","journal-title":"Iran J diabetes Obes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001369","article-title":"Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial","volume":"31","author":"Anushiravani A","year":"2019","unstructured":"Anushiravani A, Haddadi N, Pourfarmanbar M, Mohammadkarimi V. Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial. Eur J Gastroenterol Hepatol. 2019, 31:613-7. 10.1097\/MEG.0000000000001369","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80285-7","article-title":"Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial","volume":"28","author":"Par\u00e9s A","year":"1998","unstructured":"Par\u00e9s A, Planas R, Torres M, et al.. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol. 1998, 28:615-21. 10.1016\/S0168-8278(98)80285-7","journal-title":"J Hepatol"},{"key":"ref16","article-title":"The effect of silymarin on non-alcoholic fatty liver disease of children","volume":"6","author":"Famouri F","year":"2017","unstructured":"Famouri F, Salehi MM, Rostampour N, Hashemi E, Shahsanaee A. The effect of silymarin on non-alcoholic fatty liver disease of children. J HerbMed Pharmacol. 2017, 6:16-20.","journal-title":"J HerbMed Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326845-impact-of-silymarin-supplementation-on-liver-function-and-enzyme-profiles-in-diverse-chronic-liver-disease-etiologies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T15:13:16Z","timestamp":1735053196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326845-impact-of-silymarin-supplementation-on-liver-function-and-enzyme-profiles-in-diverse-chronic-liver-disease-etiologies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.76313","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,24]]}}}